-- 根據週三在上海證券交易所發布的公告顯示，浙江巨化（SHA:600160）第一季歸屬於股東的淨利潤年增46%，從去年同期的8.038億元人民幣增至11.7億元人民幣。 每股盈餘較去年同期成長0.434元人民幣，高於去年同期的0.298元。 營業收入較去年同期成長3.8%，從去年同期的58億元增加至60.2億元。 這家中國化工產品製造商的股價在午盤交易中上漲了1%。
Related Articles
Research
Research Alert: Gsk Q1 Beat As Specialty Medicines Remains Strong, Reiterates 2026 Outlook
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:GSK delivered a Q1 2026 beat with sales growing 2% Y/Y (5% CER), led by Specialty Medicines (+10% or +14% CER), particularly oncology with strong Jemperli and Ojjaara uptake, while Vaccines grew 4% CER on record Shingrix sales. Core EPS grew 4% or 9% CER to GBP0.465, ahead of the consensus of GBP0.44, supported by a favorable product mix and cost control that lifted the core operating margin by 1.0%-pt or 1.8%-pts CER. We view the Q1 update positively given the beat and margin expansion, though we are mindful of currency headwinds. GSK reiterated its 2026 guidance for 3%-5% sales growth and 7%-9% core operating profit growth (CER), which is broadly aligned with that of several peers like Sanofi and Roche despite implying slower growth versus 2025. We expect revenue to be supported by key Specialty Medicines products, with GSK targeting the segment to contribute more than 50% of sales by 2031 (Q1 2026: 42%), while recent acquisitions provide a much-needed boost to growth and the drug pipeline, in our view.
$GSK
Research
Research Alert: Ubs Q1 Beats On Integration And Ib Strength; Capital Requirements Cloud Outlook
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:UBS delivered exceptional Q1 2026 results with net profit of USD3.0B (+80% Y/Y) and underlying PBT of USD4.0B (+54% Y/Y), beating consensus estimates. The strong performance reflected broad-based momentum, with underlying revenues advancing 18% and the fourth consecutive quarter of positive operating leverage. UBS achieved a pivotal milestone in the Credit Suisse integration, completing Swiss client account transfers and delivering USD0.8B in additional gross cost savings. Management expressed confidence in substantially completing the integration by year-end 2026 and achieving exit rate targets of an underlying return on CET1 capital of approximately 15% and a cost-to-income ratio below 70%. However, two significant overhangs temper the outlook: proposed Swiss capital framework changes requiring an additional USD22B in CET1 capital represent a material headwind, while elevated geopolitical risks could shift client sentiment given management's guidance for flat net interest income sequentially in Q2 2026.
$UBS
Asia
Chinese Shares Rebound on Strong Economic Start, Government Push for Security; Focus Media Up 5%
Chinese shares rebounded on Wednesday as the Politburo hailed the strong start to the year and pushed for technology and energy security.The Shanghai Composite Index, the main gauge of Chinese stocks, rose 0.7% to 4,107.51. The Shenzhen Component Index climbed 2.0% to 15,120.92.At a meeting chaired by Xi Jinping, the Communist Party of China Politburo touted the country's strong economic start to 2026, with key indicators beating expectations, while warning that recovery remains uneven.China's top leadership called for targeted fiscal and monetary support to sustain growth. Officials stressed accelerating technological self-reliance, strengthening secure industrial chains and boosting domestic demand.The meeting also urged enhanced energy and resource security, expansion of major infrastructure, and steady progress toward economic self-sufficiency amid rising external uncertainties.In company news, Focus Media Information Technology (SHE:002027) posted first-quarter attributable net profit of 1.79 billion yuan, up 58% from 1.14 billion yuan the previous year. Shares of the advertising company closed 5% higher Wednesday.
$^SSEC$^SZSE$SHE:002027